Will Eisner, a titan of the graphic novel industry, has never received mainstream recognition. A new biography is hoping to ...

The collaboration will enable Intelligent Bio Solutions to scale production of its breakthrough drug-screening device to meet ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

The partnership strengthens INBS' global manufacturing strategy, reducing reliance on a single supplier and building greater resilience into its supply chain. It further broadens capacity, ensures ...

Seers Technology, D&D Pharmatech, OliX, ABL Bio. Among the top 10 stocks by share price growth this year, four were ...

Water, advanced fluids and bio-inspired designs are coming together to radically reshape how facilities are architected and ...

“Black Artists in America: From the Bicentennial to September 11, 2001” is the third in the series curated by University of ...

Participants in the program via the Indiana Life Sciences Association can receive significant discounts—up to 75%—off list ...

There is, ultimately, no secret sauce for a successful dating app profile. One person might find your penchant for 1940s silent films pretentious, while for others, it’s a total aphrodisiac. The same ...

Gossamer Bio advances the Feb. 2026 PROSERA Phase 3 readout for seralutinib in PAH, with expanded endpoints and a new ILD trial. Learn why GOSS stock is a hold.

So should Cabaletta Bio (NASDAQ:CABA) shareholders be worried about its cash burn? In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company ...